JMI Hospital Requisite Manufacturing Limited (DSE: JHRML)
Bangladesh
· Delayed Price · Currency is BDT 52.30
-0.30 (-0.57%)
At close: Dec 19, 2024
DSE: JHRML Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 |
| Revenue | 1,876 | 1,870 | 1,852 | 1,802 | 1,731 | 1,498 | Upgrade
|
| Revenue Growth (YoY) | 0.92% | 0.98% | 2.79% | 4.10% | 15.54% | 15.09% | Upgrade
|
| Cost of Revenue | 1,297 | 1,292 | 1,273 | 1,238 | 1,111 | 923 | Upgrade
|
| Gross Profit | 579.72 | 578.24 | 578.58 | 564.29 | 619.43 | 575.08 | Upgrade
|
| Selling, General & Admin | 153.14 | 152.27 | 145.16 | 134.28 | 127.45 | 117.72 | Upgrade
|
| Other Operating Expenses | 0.95 | 0.9 | 0.59 | 0.44 | 0.39 | 0.72 | Upgrade
|
| Operating Expenses | 154.09 | 153.16 | 145.75 | 134.73 | 127.85 | 118.44 | Upgrade
|
| Operating Income | 425.63 | 425.08 | 432.82 | 429.57 | 491.58 | 456.64 | Upgrade
|
| Interest Expense | -71.64 | -70.75 | -73.34 | -99.28 | -112.18 | -79.2 | Upgrade
|
| Interest & Investment Income | 9.67 | 8.54 | 14.21 | 7.02 | 0.94 | 1.14 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.51 | 0.51 | - | - | -0.14 | -1.14 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.3 | 3.3 | 3.3 | 3.3 | 2.41 | 2.04 | Upgrade
|
| EBT Excluding Unusual Items | 367.47 | 366.68 | 376.99 | 340.61 | 382.62 | 379.49 | Upgrade
|
| Pretax Income | 367.47 | 366.68 | 376.99 | 340.61 | 382.62 | 379.49 | Upgrade
|
| Income Tax Expense | 73.92 | 73.57 | 74.7 | 15.59 | 157.61 | 162.08 | Upgrade
|
| Earnings From Continuing Operations | 293.55 | 293.11 | 302.29 | 325.02 | 225 | 217.41 | Upgrade
|
| Minority Interest in Earnings | 0.02 | 0.02 | - | - | - | - | Upgrade
|
| Net Income | 293.57 | 293.13 | 302.29 | 325.02 | 225 | 217.41 | Upgrade
|
| Net Income to Common | 293.57 | 293.13 | 302.29 | 325.02 | 225 | 217.41 | Upgrade
|
| Net Income Growth | -3.32% | -3.03% | -6.99% | 44.45% | 3.49% | 18.03% | Upgrade
|
| Shares Outstanding (Basic) | 125 | 125 | 125 | 100 | 90 | 90 | Upgrade
|
| Shares Outstanding (Diluted) | 125 | 125 | 125 | 100 | 90 | 90 | Upgrade
|
| Shares Change (YoY) | - | - | 25.34% | 11.07% | - | 8.15% | Upgrade
|
| EPS (Basic) | 2.34 | 2.34 | 2.41 | 3.25 | 2.50 | 2.42 | Upgrade
|
| EPS (Diluted) | 2.34 | 2.34 | 2.41 | 3.25 | 2.50 | 2.42 | Upgrade
|
| EPS Growth | -3.32% | -3.03% | -25.80% | 30.06% | 3.49% | 9.13% | Upgrade
|
| Free Cash Flow | 40.41 | 124.11 | 117.67 | 243.49 | 43.83 | 397.91 | Upgrade
|
| Free Cash Flow Per Share | 0.32 | 0.99 | 0.94 | 2.44 | 0.49 | 4.42 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | 0.500 | 1.250 | - | 1.000 | Upgrade
|
| Dividend Growth | 100.00% | 100.00% | -60.00% | - | - | 0% | Upgrade
|
| Gross Margin | 30.90% | 30.92% | 31.24% | 31.32% | 35.79% | 38.39% | Upgrade
|
| Operating Margin | 22.68% | 22.73% | 23.37% | 23.84% | 28.40% | 30.48% | Upgrade
|
| Profit Margin | 15.65% | 15.67% | 16.32% | 18.04% | 13.00% | 14.51% | Upgrade
|
| Free Cash Flow Margin | 2.15% | 6.64% | 6.35% | 13.51% | 2.53% | 26.56% | Upgrade
|
| EBITDA | 572.34 | 570.55 | 587.04 | 594.37 | 673.16 | 574.3 | Upgrade
|
| EBITDA Margin | 30.50% | 30.51% | 31.70% | 32.99% | 38.89% | 38.34% | Upgrade
|
| D&A For EBITDA | 146.72 | 145.47 | 154.22 | 164.8 | 181.58 | 117.66 | Upgrade
|
| EBIT | 425.63 | 425.08 | 432.82 | 429.57 | 491.58 | 456.64 | Upgrade
|
| EBIT Margin | 22.68% | 22.73% | 23.37% | 23.84% | 28.40% | 30.48% | Upgrade
|
| Effective Tax Rate | 20.12% | 20.06% | 19.82% | 4.58% | 41.19% | 42.71% | Upgrade
|
| Advertising Expenses | - | 9.39 | 9.82 | 8.57 | 6.29 | 5.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.